# Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study

> **NCT01284829** · NA · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 87 (actual)

## Conditions studied

- Adrenal Tumors

## Interventions

- **OTHER:** FDG-PET scan

## Key facts

- **NCT ID:** NCT01284829
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02-04
- **Primary completion:** 2013-10-10
- **Final completion:** 2023-04-05
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01284829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01284829, "Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01284829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*